Global Long-Acting Injectable (LAI) Antipsychotic Supply, Demand and Key Producers, 2023-2029

Global Long-Acting Injectable (LAI) Antipsychotic Supply, Demand and Key Producers, 2023-2029

The global Long-Acting Injectable (LAI) Antipsychotic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.

This report studies the global Long-Acting Injectable (LAI) Antipsychotic demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Long-Acting Injectable (LAI) Antipsychotic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-Acting Injectable (LAI) Antipsychotic that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Long-Acting Injectable (LAI) Antipsychotic total market, 2018-2029, (USD Million)

Global Long-Acting Injectable (LAI) Antipsychotic total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Long-Acting Injectable (LAI) Antipsychotic total market, key domestic companies and share, (USD Million)

Global Long-Acting Injectable (LAI) Antipsychotic revenue by player and market share 2018-2023, (USD Million)

Global Long-Acting Injectable (LAI) Antipsychotic total market by Type, CAGR, 2018-2029, (USD Million)

Global Long-Acting Injectable (LAI) Antipsychotic total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Long-Acting Injectable (LAI) Antipsychotic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alkermes, Eli Lilly and Company, Janssen Global Services, LLC, Abilify Maintena, Haldol, Otsuka Pharmaceutical, Aristada and Prolixin, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-Acting Injectable (LAI) Antipsychotic market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Long-Acting Injectable (LAI) Antipsychotic Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Long-Acting Injectable (LAI) Antipsychotic Market, Segmentation by Type
Aripiprazole
Fluphenazine
Haloperidol
Others

Global Long-Acting Injectable (LAI) Antipsychotic Market, Segmentation by Application
Hospital
Retail Pharmacy
Others

Companies Profiled:
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC
Abilify Maintena
Haldol
Otsuka Pharmaceutical
Aristada
Prolixin

Key Questions Answered

1. How big is the global Long-Acting Injectable (LAI) Antipsychotic market?

2. What is the demand of the global Long-Acting Injectable (LAI) Antipsychotic market?

3. What is the year over year growth of the global Long-Acting Injectable (LAI) Antipsychotic market?

4. What is the total value of the global Long-Acting Injectable (LAI) Antipsychotic market?

5. Who are the major players in the global Long-Acting Injectable (LAI) Antipsychotic market?

6. What are the growth factors driving the market demand?